Vancouver, British Columbia–(Newsfile Corp. – August 2, 2022) – NervGen Pharma Corp., (TSXV: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, will present the study design for its ...
Philadelphia, Pennsylvania and Oxfordshire, United Kingdom–(Newsfile Corp. – July 21, 2022) – Adaptimmune Therapeutics plc (NASDAQ: ADAP), a leader in cell therapy to treat cancer, will report financial results and provide business updates for the second quarter ended June 30, ...
Toronto, Ontario–(Newsfile Corp. – July 19, 2022) – Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (“Leveljump” or the “Company”), a Canadian leader in B2B telehealth solutions, announces that it will not be proceeding with its Telehospital Corp. purchase ...
New York, New York–(Newsfile Corp. – July 19, 2022) – Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) (“Plantable” or the “Company“) today announces that its Prostate Cancer Trial at Weill Cornell Medicine, NewYork-Presbyterian and at Johns Hopkins Sidney Kimmel Comprehensive ...
Vancouver, British Columbia–(Newsfile Corp. – July 18, 2022) – Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) (“Bloom” or the “Company“), a leading provider of operational health and health technology, announces that it has closed the second tranche ...
Toronto, Ontario–(Newsfile Corp. – July 14, 2022) – Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) (“Scryb” or the “Company”), is pleased to report on the signing of an agreement with a leading cybersecurity firm and advisor to Government of Canada departments ...
Vancouver, British Columbia–(Newsfile Corp. – July 14, 2022) – NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) (“NervGen” the “Company”), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, announced that it has ...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia–(Newsfile Corp. – July 11, 2022) – NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) (“NervGen” the “Company”), a clinical stage biotech company dedicated to ...
Vancouver, British Columbia–(Newsfile Corp. – July 6, 2022) – Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) (“Bloom” or the “Company“), a leading provider of operational health and health technology, announces that it has closed an initial tranche ...
Toronto, Ontario–(Newsfile Corp. – July 5, 2022) – Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (“Leveljump” or the “Company“), a Canadian leader in B2B telehealth solutions, announces that it will not be proceeding with its acquisition of 7127651 ...